State Street Corp Has $7.48 Million Stock Holdings in OraSure Technologies, Inc. (NASDAQ:OSUR)

State Street Corp decreased its position in OraSure Technologies, Inc. (NASDAQ:OSUR - Free Report) by 12.8% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 1,751,422 shares of the medical instruments supplier's stock after selling 257,093 shares during the period. State Street Corp owned about 2.35% of OraSure Technologies worth $7,479,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Systematic Financial Management LP increased its stake in OraSure Technologies by 14.9% in the 3rd quarter. Systematic Financial Management LP now owns 1,252,112 shares of the medical instruments supplier's stock valued at $5,347,000 after buying an additional 162,364 shares during the period. Jacobs Levy Equity Management Inc. raised its holdings in shares of OraSure Technologies by 66.5% during the third quarter. Jacobs Levy Equity Management Inc. now owns 524,950 shares of the medical instruments supplier's stock worth $2,242,000 after acquiring an additional 209,580 shares in the last quarter. Atom Investors LP acquired a new stake in OraSure Technologies during the third quarter valued at $49,000. Walleye Capital LLC purchased a new position in OraSure Technologies in the third quarter valued at about $835,000. Finally, Martingale Asset Management L P increased its position in OraSure Technologies by 8.2% in the 3rd quarter. Martingale Asset Management L P now owns 262,873 shares of the medical instruments supplier's stock worth $1,122,000 after purchasing an additional 19,926 shares during the last quarter. Hedge funds and other institutional investors own 93.50% of the company's stock.

Analyst Upgrades and Downgrades

Separately, StockNews.com lowered shares of OraSure Technologies from a "buy" rating to a "hold" rating in a research report on Monday, December 9th.

OraSure Technologies Trading Down 0.5 %

OraSure Technologies stock traded down $0.02 during mid-day trading on Friday, hitting $3.62. 821,799 shares of the company's stock were exchanged, compared to its average volume of 895,530. OraSure Technologies, Inc. has a 1-year low of $3.57 and a 1-year high of $8.45. The stock has a 50 day moving average of $3.96 and a two-hundred day moving average of $4.16. The stock has a market cap of $270.03 million, a P/E ratio of 24.13 and a beta of 0.03.

OraSure Technologies (NASDAQ:OSUR - Get Free Report) last issued its quarterly earnings data on Wednesday, November 6th. The medical instruments supplier reported ($0.06) earnings per share for the quarter, beating analysts' consensus estimates of ($0.08) by $0.02. The business had revenue of $39.92 million for the quarter, compared to the consensus estimate of $38.97 million. OraSure Technologies had a return on equity of 3.55% and a net margin of 5.07%. The firm's revenue was down 55.2% compared to the same quarter last year. During the same period last year, the business earned $0.27 EPS. As a group, research analysts predict that OraSure Technologies, Inc. will post -0.08 EPS for the current fiscal year.

OraSure Technologies Profile

OraSure Technologies, Inc, together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company's products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.